The EVC’s Malaria Research Program was established by Dr. Mary Galinski beginning at the time of the opening of the vaccine center premises in 1999. This highly successful program has grown rapidly in its first five years at the EVC. Dr. Galinski and her colleagues have been known internationally for their discoveries of several P. vivax and P. falciparum merozoite vaccine candidates, basic studies of simian malaria models, and investigations of the molecular mechanisms that underpin antigenic variation. Dr. Galinski brought these major lines of research to Emory and has since expanded her program to include pathogenesis, epidemiology and vaccine testing components. She also facilitated the development of the current broad-based multi-investigator malaria research effort at the EVC.